Oragenics extends ATM equity distribution agreement with Dawson James

ORAGENICS INC

On January 22, 2026, Oragenics amended its at-the-market sales agreement with Dawson James Securities.
The amendment extends the agreement term until all shares are sold or the shelf registration expires.
No other terms of the original October 11, 2024 agreement were modified.
The ATM facility allows the company to sell common stock from time to time on NYSE American.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ORAGENICS INC amended Sales Agreement with Dawson James Securities Inc. (effective 2026-01-22).

Action: amendment
Agreement: atm program
Counterparty: Dawson James Securities Inc.
Effective: 2026-01-22

Exact text from the filing

On January 22, 2026, the Company and Sales Agent entered into an amendment to the Sales Agreement (the “ Amendment ”), to extend the term of the Sales Agreement to expire at the earlier of (i) the issuance and sale of all of the Shares to or through the Sales Agent and (ii) the later of (X) the expiration of the Company’s Shelf Registration Statement on Form S-3 to be filed pursuant to Rule 415(a)(5) under the Securities Act and (Y) the expiration of any replacement registration statement filed with the Securities and Exchange Commission pursuant to Rule 415(a)(6) under the Securities Act.

View on SEC.gov

197 material agreements filed in the last 30 days. Browse all material agreements →

ORAGENICS INC filing history →

Source: SEC EDGAR

accession 0001493152-26-003237

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.